NCT04624451终止不适用
Evaluation of Intravenous Dalbavancin for Treatment of Peritonitis in Peritoneal Dialysis Patients
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 入组人数
- 2
- 试验地点
- 1
- 主要终点
- Clinical cure
研究概览
简要总结
This study evaluates the use of Dalbavancin 1500 mg IV x 1 dose for treating patients with gram positive peritonitis in patients requiring peritoneal dialysis.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients > 18 years of age actively receiving peritoneal dialysis diagnosed with a gram + peritonitis determined to be a good candidate for dalbavancin treatment by the attending nephrology attending.
排除标准
- •Patients with contraindications to dalbavancin therapy
结局指标
主要结局
Clinical cure
时间窗: 28 days
resolution of signs and symptoms (e.g. abdominal pain), bacterial eradication, reduction in clinical markers (e.g. peritoneal fluid findings, CRP, etc), and return of peritoneal dialysis functionality
次要结局
- Treatment emergent adverse events(28 days)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
4 期
Evaluation of Intravenous and Intraperitoneal Pharmacokinetics of Dalbavancin in Peritoneal Dialysis PatientsInfectious PeritonitisNCT02940730University of Colorado, Denver10
已完成
4 期
Dalbavancin For The Treatment of Gram Positive Osteoarticular InfectionsSeptic ArthritisBone InfectionJoint InfectionOsteomyelitisProsthetic Joint InfectionNCT03426761Infectious Diseases Physicians, Inc.41
已完成
3 期
Single Dose vs. Two Dose Regimen of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure InfectionsAbscessSurgical Site InfectionWound InfectionCellulitisNCT02127970Durata Therapeutics Inc., an affiliate of Allergan plc698
已完成
不适用
Dalbavancin Real-life Utilization in Diabetic Patients Suffering From Infections (DALBADIA)InfectionDiabetesNCT04959799Aziende Chimiche Riunite Angelini Francesco S.p.A98
终止
2 期
Substance Use Disorder (SUD)-Associated Infections' Treatment With Dalbavancin ENabling OUtpatient TransitionGram-Positive Bacterial InfectionsGram-Positive BacteraemiaSubstance Use DisordersIntravenous Substance AbuseNCT04847921University of Colorado, Denver11